TIMKEN CO Earnings Per Share Disclosure
| 2025 | 2024 | 2023 | |||||||||
| Numerator: | |||||||||||
| Net income attributable to The Timken Company | $ | 288.4 | $ | 352.7 | $ | 394.1 | |||||
| Denominator: | |||||||||||
| Weighted average number of shares outstanding - basic | 69,766,557 | 70,198,067 | 71,377,656 | ||||||||
| Effect of dilutive securities: | |||||||||||
| Stock options and awards - based on the treasury stock method | 465,149 | 552,415 | 704,228 | ||||||||
| Weighted average number of shares outstanding, assuming dilution of stock options and awards | 70,231,706 | 70,750,482 | 72,081,884 | ||||||||
| Basic earnings per share | $ | 4.13 | $ | 5.02 | $ | 5.52 | |||||
| Diluted earnings per share | $ | 4.11 | $ | 4.99 | $ | 5.47 | |||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 13, 2026 | Showing above |
| 2024 | Feb 20, 2025 | |
| 2023 | Feb 26, 2024 | |
| 2022 | Feb 16, 2023 | |
| 2021 | Feb 15, 2022 | |
| 2020 | Feb 16, 2021 | |
| 2019 | Feb 14, 2020 | |
| 2018 | Feb 15, 2019 | |
| 2017 | Feb 15, 2018 | |
| 2016 | Feb 21, 2017 | |
| 2015 | Feb 24, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.